Gene,Diplotype,ActivityScore,Phenotype,PriorityEHR,Source,URL,AccessDate
CYP2C19,*1/*2,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*22,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*24,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*3,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*35,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*36,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*37,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*4,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*5,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*6,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*7,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*8,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*22,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*24,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*35,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*36,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*37,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*22,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*24,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*35,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*36,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*37,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*22,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*24,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*35,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*36,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*37,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*22,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*24,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*35,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*36,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*37,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*22,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*24,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*35,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*36,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*37,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*11,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*13,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*15,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*17,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*18,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*28,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*38,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*22/*28,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*22/*38,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*24/*28,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*24/*38,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*28/*35,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*28/*36,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*28/*37,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*11,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*13,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*15,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*17,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*18,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*28,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*38,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*35/*38,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*36/*38,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*37/*38,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*11,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*13,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*15,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*17,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*18,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*28,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*38,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*11,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*13,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*15,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*17,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*18,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*28,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*38,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*11,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*13,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*15,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*17,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*18,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*28,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*38,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*11,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*13,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*15,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*17,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*18,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*28,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*38,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*11,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*13,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*15,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*17,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*18,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*28,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*38,N/A,CYP2C19 Intermediate Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*10,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*16,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*19,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*25,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*26,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*9,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*10,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*11,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*13,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*15,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*16,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*17,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*18,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*19,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*25,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*26,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*28,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*38,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*16,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*19,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*25,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*26,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*16,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*19,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*25,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*26,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*16,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*19,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*25,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*26,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*16,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*17,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*18,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*19,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*25,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*26,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*28,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*38,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*19,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*25,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*26,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*19,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*25,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*26,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*19,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*25,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*26,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*28,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*38,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*25/*25,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*25/*26,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*25/*28,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*25/*38,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*26/*26,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*26/*28,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*26/*38,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*10,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*11,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*13,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*15,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*16,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*17,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*18,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*19,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*25,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*26,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*28,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*38,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*9,N/A,CYP2C19 Likely Intermediate Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*22,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*24,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*35,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*36,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*37,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*22,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*24,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*35,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*36,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*37,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*22,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*24,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*35,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*36,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*37,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*10,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*16,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*19,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*25,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*26,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*9,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*22/*25,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*22/*26,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*24/*25,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*24/*26,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*25/*35,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*25/*36,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*25/*37,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*26/*35,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*26/*36,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*26/*37,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*10,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*16,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*19,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*25,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*26,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*9,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*10,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*16,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*19,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*25,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*26,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*9,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*10,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*16,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*19,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*25,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*26,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*9,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*10,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*16,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*19,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*25,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*26,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*9,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*10,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*16,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*19,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*25,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*26,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*9,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*10,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*16,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*19,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*25,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*26,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*9,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*22,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*24,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*35,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*36,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*37,N/A,CYP2C19 Likely Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*1,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*11,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*13,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*15,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*18,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*28,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*38,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*11,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*13,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*15,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*18,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*28,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*38,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*13,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*15,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*18,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*28,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*38,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*15,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*18,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*28,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*38,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*18,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*28,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*38,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*28/*28,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*28/*38,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*38/*38,N/A,CYP2C19 Normal Metabolizer ,Normal/Routine/Low Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*2,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*22,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*24,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*3,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*35,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*36,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*37,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*4,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*5,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*6,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*7,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*8,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*22/*22,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*22/*24,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*22/*35,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*22/*36,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*22/*37,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*24/*24,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*24/*35,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*24/*36,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*24/*37,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*22,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*24,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*3,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*35,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*36,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*37,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*4,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*5,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*6,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*7,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*8,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*35/*35,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*35/*36,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*35/*37,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*36/*36,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*36/*37,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*37/*37,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*22,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*24,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*35,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*36,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*37,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*4,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*5,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*6,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*7,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*8,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*22,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*24,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*35,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*36,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*37,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*5,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*6,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*7,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*8,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*22,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*24,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*35,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*36,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*37,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*6,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*7,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*8,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*22,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*24,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*35,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*36,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*37,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*7,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*8,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*22,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*24,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*35,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*36,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*37,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*8,N/A,CYP2C19 Poor Metabolizer,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*17,N/A,CYP2C19 Rapid Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*17,N/A,CYP2C19 Rapid Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*17,N/A,CYP2C19 Rapid Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*17,N/A,CYP2C19 Rapid Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*18,N/A,CYP2C19 Rapid Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*28,N/A,CYP2C19 Rapid Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*38,N/A,CYP2C19 Rapid Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*17,N/A,CYP2C19 Ultrarapid Metabolizer ,Abnormal/Priority/High Risk,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*12,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*14,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*1/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*12,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*14,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*10/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*12,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*14,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*11/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*12,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*13,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*14,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*15,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*16,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*17,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*18,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*19,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*22,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*24,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*25,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*26,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*28,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*35,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*36,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*37,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*12/*38,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*14,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*13/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*14,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*15,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*16,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*17,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*18,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*19,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*22,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*24,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*25,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*26,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*28,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*35,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*36,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*37,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*14/*38,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*15/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*16/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*17/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*18/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*19/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*12,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*14,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*2/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*22/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*22/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*22/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*22/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*22/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*22/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*22/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*23/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*23/*24,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*23/*25,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*23/*26,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*23/*28,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*23/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*23/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*23/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*23/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*23/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*23/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*23/*35,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*23/*36,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*23/*37,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*23/*38,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*24/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*24/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*24/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*24/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*24/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*24/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*25/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*25/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*25/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*25/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*25/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*25/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*26/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*26/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*26/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*26/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*26/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*26/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*28/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*28/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*28/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*28/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*28/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*28/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*29/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*29/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*29/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*29/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*29/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*29/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*29/*35,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*29/*36,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*29/*37,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*29/*38,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*12,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*14,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*3/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*30/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*30/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*30/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*30/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*30/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*30/*35,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*30/*36,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*30/*37,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*30/*38,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*31/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*31/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*31/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*31/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*31/*35,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*31/*36,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*31/*37,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*31/*38,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*32/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*32/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*32/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*32/*35,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*32/*36,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*32/*37,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*32/*38,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*33/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*33/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*33/*35,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*33/*36,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*33/*37,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*33/*38,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*34/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*34/*35,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*34/*36,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*34/*37,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*34/*38,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*12,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*14,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*4/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*12,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*14,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*5/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*12,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*14,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*6/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*12,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*14,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*7/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*12,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*14,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*8/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*12,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*14,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*23,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*29,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*30,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*31,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*32,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*33,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21
CYP2C19,*9/*34,N/A,Indeterminate,None,CPIC,https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/,8/17/21